Ocular Therapeutix Competitors and Similar CompaniesClear all

Ocular Therapeutix's competitors and similar companies include Opthea.
Ocular Therapeutix
Ocular Therapeutix
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Opthea
Opthea
Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.
Founding Date
Founding Date
2006
Founding Date
2012
Type
Type
Public
Type
Public
Tags
Locations
Locations
Bedford, US HQ
Bedford, US
Bedford, US
Locations
South Yarra, AU HQ
Toorak, AU
Employees
Employees
16740% increase
Employees
33
Valuation ($)
Valuation ($)
1.8 b
Valuation ($)
711.2 m

Financial

Revenue (est.)
Revenue (est.)
$52m (FY, 2025)
Revenue (est.)
$25k (FY, 2025)
Cost of goods
Cost of goods
$6.6m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$45.4m (FY, 2025)
Gross profit
$146k (FY, 2025)
Net income
Net income
($265.9m) (FY, 2025)
Net income
($162.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 73.3m
Total funding raised
$ 67.6m
For sources of this data, please see the company profile

View Company Profiles

Opthea
HQ
South Yarra, AU
Employees
33

Opthea (formerly Circadian Technologies) is a biopharmaceutical company developing a therapy for the treatment of retinal diseases.

View company